Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Baudax Bio, Inc. (BXRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 8-K Quarterly results
10/06/2023 8-K Investor presentation
Docs: "Investor Presentation of Baudax Bio, Inc.",
"Investor Presentation of Baudax Bio, Inc."
09/29/2023 8-K Quarterly results
08/25/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Purchase Agreement, between Baudax Bio, Inc. and Alumni Capital LP"
08/24/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Certificate of Designation of Preferences, Rights and Limitations of Series C Preferred Stock",
"Certificate of Designation of Preferences, Rights and Limitations of Series C Preferred Stock"
08/21/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "Opinion of Goodwin Procter LLP",
"Form of Series E Pre-funded Warrant",
"Form of Series A-7 Warrant",
"Opinion of Goodwin Procter LLP",
"Form of Securities Purchase Agreement"
08/16/2023 8-K Quarterly results
Docs: "Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update"
08/09/2023 8-K/A Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Business Section of Baudax Bio, Inc",
"Risk Factors of Baudax Bio, Inc"
07/31/2023 8-K/A Quarterly results
07/25/2023 8-K Quarterly results
07/17/2023 8-K Quarterly results
07/05/2023 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...
Docs: "Agreement and Plan of Merger, by and among Baudax Bio, Inc., Bounce Merger Sub I, Inc., Bounce Merger Sub II, LLC and TeraImmune, Inc.",
"Certificate of Designations of Series X Non-Voting Convertible Preferred Stock",
"Forbearance Agreement, by and among Baudax Bio, Inc, Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and the Lender party hereto"
06/28/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the registration statements on Form S-3, in the registration statements on Form S-8 and in the registration statements on Form S-1 of our report dated March 16, 2022, except for Note 4, as to which the date is June 28, 2023 with respect to the consolidated financial statements of Baudax Bio, Inc. /s/ KPMG LLP Philadelphia, Pennsylvania June 28, 2023",
"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statements of Baudax Bio, Inc. on Form S­3 . 333-235408, 333-243488 and 333-253117), Form S­8 . 333-235377, 333-253118, 333-253120, 333-263606 and 333-263608) and Form S-1 . Nos. 333-266499, 333-268251 and 333-271161) of our report dated February 23, 2023, except for Note 4, as to which the date is June 28, 2023, on our audit of the financial statements as of December 31, 2022 and for the year then ended, and the retrospective adjustments to the 2021 financial statements discussed in Notes 1 and 3 to the financial statements.. Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company's ability to continue as a g..."
05/19/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/12/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Baudax Bio Reports First Quarter Financial Results and Provides Business Update"
05/10/2023 8-K Investor presentation
Docs: "Investor Presentation of Baudax Bio, Inc."
04/25/2023 8-K Quarterly results
04/04/2023 8-K/A Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp...
Docs: "Amendment No. 5 to Credit Agreement, by and among Baudax Bio, Inc., Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and the Lenders party thereto",
"CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***] HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. ASSET TRANSFER AGREEMENT among ALKERMES PHARMA IRELAND LIMITED"
03/31/2023 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp...
Docs: "Amendment No. 5 to Credit Agreement, by and among Baudax Bio, Inc., Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and the Lenders party thereto",
"Common Stock Purchase Warrant, in favor of MAM Eagle Lender, LLC",
"Amendment No. 5 to Credit Agreement, by and among Baudax Bio, Inc., Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and the Lenders party thereto",
"Registration Rights Agreement between the Baudax Bio, Inc. and MAM Eagle Lender, LLC"
03/27/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Top Line Results Expected Late April/Early May"
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
03/03/2023 8-K Investor presentation
Docs: "Investor Presentation of Baudax Bio, Inc."
02/23/2023 8-K Quarterly results
Docs: "Baudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business Update"
01/24/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000"
01/09/2023 8-K Investor presentation
Docs: "Investor Presentation of Baudax Bio, Inc.",
"Investor Presentation of Baudax Bio, Inc."
12/30/2022 8-K Quarterly results
12/05/2022 8-K Quarterly results
12/01/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Amendment No. 3 to Credit Agreement, by and among Baudax Bio, Inc., Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and the Lenders party thereto",
"Amendment No. 3 to Credit Agreement, by and among Baudax Bio, Inc., Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and the Lenders party thereto"
11/30/2022 8-K Quarterly results
11/18/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
11/08/2022 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Baudax Bio Reports Third Quarter 2022 Financial Results and Business Highlights"
10/28/2022 8-K Quarterly results
09/20/2022 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Certificate of Designation of Preferences, Rights and Limitations of Series B Preferred Stock",
"Certificate of Designation of Preferences, Rights and Limitations of Series B Preferred Stock"
08/31/2022 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Form of Series A-2 Warrant (incorporated herein by reference to Exhibit 4.21 to the Company’s Registration Statement on Form S-1/A filed on August 17, 2022 (File No. 333-266499))"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy